NDC 72162-2636-02 - Fosaprepitant
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2636
- Requested NDC
- 72162-2636-02
- Package NDCs from labels
- 72162-2636-2, 72162-2636-02
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fosaprepitant - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2636-2 | Fosaprepitant | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 5 | 100 | |
| 72162-2636-2 | Fosaprepitant | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 100 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | BluePoint Laboratories | 2d30d839-bb88-46ce-a9ed-66fe32a12a7a | 2026-09-02 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | 6OZP39ZG8H |
| fosaprepitant | FOSAPREPITANT | Mylan Institutional LLC | 9b6d5ea3-2f7a-4501-9a4a-6fa1a7c2d50a | 2026-08-15 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Camber Pharmaceuticals, Inc. | 7dbdf8f5-6936-4143-b52d-96774b799a7d | 2026-08-11 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| NAVITRUX | FOSAPREPITANT | AVYXA Pharma, LLC | a41b7c3a-1376-43a7-b5b9-6ba2eba1e169 | 2026-07-29 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H |
| Fosaprepitant | FOSAPREPITANT | Northstar Rx LLC | bf207918-100d-4917-88b0-3433c0e72249 | 2026-07-09 | Warnings, Adverse reactions | ANDA209965 1731077 D35FM8T64X |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| Fosaprepitant | FOSAPREPITANT DIMEGLUMINE | Baxter Healthcare Corporation | 3ed3e0a9-a0a8-4555-9f73-2043e79e3398 | 2026-05-29 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Fosaprepitant | FOSAPREPITANT | Bryant Ranch Prepack | 679c195a-cf59-4ca5-aa05-fa35d08ddb5c | 2026-05-06 | Warnings, Adverse reactions | ANDA209965 72162-2636-2 72162-2636 72162263602 1731077 6d59bb30-4ae7-4afd-918f-05002c34ab2c 679c195a-cf59-4ca5-aa05-fa35d08ddb5c D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Eugia US LLC | 19919480-960b-4741-9611-c133d68512f5 | 2026-04-01 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| FOCINVEZ | FOSAPREPITANT DIMEGLUMINE | Steriscience Specialties Private Limited | 18a60093-cec8-1b8c-e063-6394a90a8902 | 2026-03-30 | Warnings, Adverse reactions | D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1a7d2f44-b578-4d99-a4ff-f267626064d0 | 2026-03-19 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | Hikma Pharmaceuticals USA Inc. | 1cc7d482-5d45-4621-9ffc-cd3f7c54614d | 2026-03-19 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| EMEND | FOSAPREPITANT DIMEGLUMINE | Merck Sharp & Dohme LLC | 8d66803a-6811-4c29-9c57-e16acfa87f21 | 2026-02-20 | Warnings, Adverse reactions | 1731077 D35FM8T64X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.